Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization

키워드

참고문헌 (20)

1. Younossi ZM, "The global burden of liver disease", Clin Gastroenterol Hepatol, 21, pp.1978~1991 (2023)
2. Younossi ZM, "The global epidemiology of nonalcoholic fatty liver disease(NAFLD)and nonalcoholic steatohepatitis(NASH) : a systematic review", Hepatology, 77, pp.1335~1347 (2023)
3. Rehm J, "Global burden of alcohol use disorders and alcohol liver disease", Biomedicines, 7, pp.99~ (2019)
4. Sung H, "Global cancer statistics 2020 : GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185countries", CA Cancer J Clin, 71, pp.209~249 (2021)
5. Shin E, "Expression of HLA and autoimmune pathway genes in liver biopsies of young subjects with autoimmune hepatitis type 1", J Pediatr Gastroenterol Nutr, 75, pp.269~275 (2022)
6. Fan X, "Diagnostic and prognostic significance of complement in patients with alcohol-associated hepatitis", Hepatology, 73, pp.983~997 (2021)
7. Lin CJ, "Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis", World J Hepatol, 10, pp.662~669 (2018)
8. Thorgersen EB, "The role of complement in liver injury, regeneration, and transplantation", Hepatology, 70, pp.725~736 (2019)
9. Xiao Z, "An update on the role of complement in hepatocellular carcinoma", Front Immunol, 13, pp.1007382~ (2022)
10. Ricklin D, "Complement in disease : a defence system turning offensive", Nat Rev Nephrol, 12, pp.383~401 (2016)
11. Ference BA, "Using mendelian randomization to improve the design of randomized trials", Cold Spring Harb Perspect Med, 11, pp.a040980~ (2021)
12. Song Y, "Mendelian randomization in hepatology: A review of principles, opportunities, and challenges", Hepatology (2023)[DOI]
13. Luo P, "Exploring the genetic relationship between deep vein thrombosis and plasma protein : a new research idea", Expert Rev Hematol, 15, pp.867~873 (2022)
14. Cui HK, "An integrative analysis of single-cell and bulk transcriptome and bidirectional mendelian randomization analysis identified C1Q as a novel stimulated risk gene for Atherosclerosis", Front Immunol, 14, pp.1289223~ (2023)
15. Alayash Z, "Complement C3 as a potential drug target in periodontitis : Evidence from the cis-Mendelian randomization approach", J Clin Periodontol, 51, pp.127~134 (2024)
16. Wang Q, "Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myeloma", BMC Med, 21, pp.377~ (2023)
17. Zhang S, "Investigating causal relations between genetic-related intermediate endophenotype and risk of chronic prostatitis : mendelian randomization study", Oxid Med Cell Longev, 2022, pp.4560609~ (2022)
18. Rasmussen KL, "An updated Alzheimer hypothesis : Complement C3 and risk of Alzheimer’s disease-A cohort study of 95, 442 individuals", Alzheimers Dement, 14, pp.1589~1601 (2018)
19. Shi Y, "Protein-centric omics analysis reveals circulating complements linked to nonviral liver diseases as potential therapeutic targets", Clin Mol Hepatol, 30, pp.80~97 (2024)
20. Yin Q, "Mendelian randomization analyses of chronic immune-mediated diseases, circulating inflammatory biomarkers, and cytokines in relation to liver cancer", Cancers(Basel), 15, pp.2930~ (2023)

관련 논문AI추천